These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2207706)

  • 1. Long-lasting elevation of alanine in brain produced by the antidepressant phenelzine.
    Wong JT; Baker GB; Coutts RT; Dewhurst WG
    Brain Res Bull; 1990 Jul; 25(1):179-81. PubMed ID: 2207706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
    Parent MB; Habib MK; Baker GB
    Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain.
    Tanay VA; Parent MB; Wong JT; Paslawski T; Martin IL; Baker GB
    Cell Mol Neurobiol; 2001 Aug; 21(4):325-39. PubMed ID: 11775064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.
    McKenna KF; Baker GB; Coutts RT
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):478-82. PubMed ID: 1881457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA).
    Baker GB; Wong JT; Yeung JM; Coutts RT
    J Affect Disord; 1991 Mar; 21(3):207-11. PubMed ID: 1648582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
    Paslawski T; Treit D; Baker GB; George M; Coutts RT
    Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
    Todd KG; Baker GB
    J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain.
    McManus DJ; Baker GB; Martin IL; Greenshaw AJ; McKenna KF
    Biochem Pharmacol; 1992 Jun; 43(11):2486-9. PubMed ID: 1610412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain.
    Paslawski TM; Sloley BD; Baker GB
    Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
    MacKenzie EM; Grant SL; Baker GB; Wood PL
    Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent studies on the MAO inhibitor phenelzine and its possible metabolites.
    McKenna KF; Baker GB; Coutts RT; Rauw G; Mozayani A; Danielson TJ
    J Neural Transm Suppl; 1990; 32():113-8. PubMed ID: 1982447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute and chronic administration of phenelzine on 2-phenylethylamine levels in rat brain.
    Baker GB; LeGatt DF; Coutts RT
    Proc West Pharmacol Soc; 1982; 25():417-20. PubMed ID: 7122532
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A; Glover V; Oxenkrug GF; Sandler M
    Neurosci Lett; 1989 Dec; 107(1-3):331-4. PubMed ID: 2616044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of chronic administration of tranylcypromine and phenelzine on rat brain levels of the catecholamines and their O-methylated metabolites.
    Baker JM; Baker GB; Coutts RT; LeGatt DF
    Proc West Pharmacol Soc; 1983; 26():361-4. PubMed ID: 6889365
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
    Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT; Mozayani A; Danielson TJ; Baker GB
    J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution.
    Dourish CT; Dewar KM; Dyck LE; Boulton AA
    Psychopharmacology (Berl); 1983; 81(2):122-5. PubMed ID: 6415742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain.
    Yamada N; Takahashi S; Todd KG; Baker GB; Paetsch PR
    J Pharm Sci; 1993 Sep; 82(9):934-7. PubMed ID: 7901387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant.
    Dourish CT; Boulton AA; Dyck LE
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):383-8. PubMed ID: 6891805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.